Business Description
Beyond Air Inc. is a medical device and biopharmaceutical company focused on using nitric oxide (NO) to treat a range of serious health conditions. Its main product, the LungFit platform, is already approved to treat a dangerous lung condition in newborns, while other versions of the device are being tested for respiratory infections and a lung disease patients can manage at home. The company is also exploring the use of high-concentration nitric oxide to fight tumors, and is working on a treatment for autism and other neurological disorders through a research partnership with Hebrew University of Jerusalem. Founded in 2011 and based in Garden City, New York, Beyond Air operates across three distinct business areas targeting lung disease, cancer, and neurology.
